Provide a genomic-based, comprehensive, individualized risk assessment for early-stage cancers in specific settings.
Find and monitor cancer after treatment and get insights to guide therapy selection.
Understand how genomic testing can help to guide your individualized treatment options.
Experience our comprehensive portfolio of diagnostic tests through the lens of a specific cancer type
See how Precision Oncology is enabling more personalize cancer care
Jennifer Racz, MD, Director of Medical Affairs, Oncology at Exact Sciences, provides an overview of the landmark TAILORx and RxPONDER clinical trials.
You are now leaving this site. Any third party link you select from this site may take you to a website that is not affiliated with Exact Sciences.
